Log in

Blackrock Health Sciences Trust Stock Price, News & Analysis (NYSE:BME)

+0.16 (+0.42 %)
(As of 10/20/2019 04:00 PM ET)
Today's Range
Now: $37.85
50-Day Range
MA: $37.86
52-Week Range
Now: $37.85
Volume22,797 shs
Average Volume31,601 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.06%
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Industry, Sector and Symbol

Industry Closed-End Fund - Equity



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive BME News and Ratings via Email

Sign-up to receive the latest news and ratings for BME and its competitors with MarketBeat's FREE daily newsletter.

Blackrock Health Sciences Trust (NYSE:BME) Frequently Asked Questions

What is Blackrock Health Sciences Trust's stock symbol?

Blackrock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."

How often does Blackrock Health Sciences Trust pay dividends? What is the dividend yield for Blackrock Health Sciences Trust?

Blackrock Health Sciences Trust announced a monthly dividend on Tuesday, October 1st. Shareholders of record on Tuesday, October 15th will be given a dividend of $0.20 per share on Thursday, October 31st. This represents a $2.40 annualized dividend and a yield of 6.34%. The ex-dividend date is Friday, October 11th. View Blackrock Health Sciences Trust's Dividend History.

Has Blackrock Health Sciences Trust been receiving favorable news coverage?

News articles about BME stock have trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Blackrock Health Sciences Trust.

Who are some of Blackrock Health Sciences Trust's key competitors?

What other stocks do shareholders of Blackrock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Blackrock Health Sciences Trust investors own include Gilead Sciences (GILD), AbbVie (ABBV), New Residential Investment (NRZ), Verizon Communications (VZ), Blackstone Group (BX), John Hancock Preferred Income Fund III (HPS), Vereit (VER), Johnson & Johnson (JNJ), Tanger Factory Outlet Centers (SKT) and AT&T (T).

Who are Blackrock Health Sciences Trust's key executives?

Blackrock Health Sciences Trust's management team includes the folowing people:
  • Mr. John M. Perlowski, Chief Exec. Officer and Pres (Age 55)
  • Mr. Neal J. Andrews, Chief Financial Officer (Age 53)
  • Mr. Charles Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer (Age 52)
  • Mr. Michael D. Carey CFA, Managing Director and Portfolio Mang.
  • Mr. Jay M. Fife, Treasurer (Age 49)

Who are Blackrock Health Sciences Trust's major shareholders?

Blackrock Health Sciences Trust's stock is owned by a number of of retail and institutional investors. Top institutional investors include Wealthcare Advisory Partners LLC (0.00%). View Institutional Ownership Trends for Blackrock Health Sciences Trust.

Which major investors are selling Blackrock Health Sciences Trust stock?

BME stock was sold by a variety of institutional investors in the last quarter, including Wealthcare Advisory Partners LLC. View Insider Buying and Selling for Blackrock Health Sciences Trust.

How do I buy shares of Blackrock Health Sciences Trust?

Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Blackrock Health Sciences Trust's stock price today?

One share of BME stock can currently be purchased for approximately $37.85.

What is Blackrock Health Sciences Trust's official website?

The official website for Blackrock Health Sciences Trust is http://www2.blackrock.com/.

How can I contact Blackrock Health Sciences Trust?

Blackrock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052.

MarketBeat Community Rating for Blackrock Health Sciences Trust (NYSE BME)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  101 (Vote Outperform)
Underperform Votes:  111 (Vote Underperform)
Total Votes:  212
MarketBeat's community ratings are surveys of what our community members think about Blackrock Health Sciences Trust and other stocks. Vote "Outperform" if you believe BME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BME will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel